Dow Jones

42,732.13

0.80%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

ACIU

AC Immune (ACIU)

AC Immune SA

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACIU

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/12/2024	16:16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
13/12/2024	16:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ACIU	AC Immune SA
10/12/2024	06:00	GlobeNewswire Inc.	AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome	NASDAQ:ACIU	AC Immune SA
14/11/2024	06:00	GlobeNewswire Inc.	AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease	NASDAQ:ACIU	AC Immune SA
13/11/2024	06:00	GlobeNewswire Inc.	AC Immune to Present at the Jefferies 2024 London Healthcare Conference	NASDAQ:ACIU	AC Immune SA
05/11/2024	06:00	GlobeNewswire Inc.	AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update	NASDAQ:ACIU	AC Immune SA
27/09/2024	15:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACIU	AC Immune SA
06/08/2024	15:50	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ACIU	AC Immune SA
31/07/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACIU	AC Immune SA
26/07/2024	15:53	Edgar (US Regulatory)	Form F-3/A - Registration statement by foreign private issuers: [Amend]	NASDAQ:ACIU	AC Immune SA
09/02/2024	15:30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ACIU	AC Immune SA
03/01/2024	07:10	GlobeNewswire Inc.	AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases	NASDAQ:ACIU	AC Immune SA
27/06/2023	12:30	AllPennyStocks.com	Biotech Pops On FDA Fast Track Designation	NASDAQ:ACIU	AC Immune SA
27/06/2023	07:23	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ACIU	AC Immune SA
27/06/2023	07:11	Dow Jones News	AC Immunity Shares Jump 18% After Fast-Track Designation on Alzheimer's Treatment	NASDAQ:ACIU	AC Immune SA
16/03/2023	06:32	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:ACIU	AC Immune SA
10/02/2023	15:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACIU	AC Immune SA
01/12/2022	07:45	TipRanks	H.C. Wainwright Keeps Their Buy Rating on AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
01/11/2022	23:45	TipRanks	SVB Securities Sticks to Its Buy Rating for AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
31/10/2022	05:15	TipRanks	AC Immune SA (ACIU) Receives a Buy from H.C. Wainwright	NASDAQ:ACIU	AC Immune SA
28/08/2022	22:15	TipRanks	SVB Securities Keeps Their Buy Rating on AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
11/07/2022	07:40	TipRanks	SVB Securities Thinks AC Immune SA’s Stock is Going to Recover	NASDAQ:ACIU	AC Immune SA
19/06/2022	02:05	TipRanks	H.C. Wainwright Sticks to Their Buy Rating for AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
16/06/2022	05:57	Dow Jones News	AC Immune Shares Fall Premarket on Alzheimer's Study Miss	NASDAQ:ACIU	AC Immune SA
29/04/2022	05:26	TipRanks	H.C. Wainwright Thinks AC Immune SA’s Stock is Going to Recover	NASDAQ:ACIU	AC Immune SA
21/12/2021	01:11	TipRanks	Leerink Partners Sticks to Its Buy Rating for AC Immune SA (ACIU)	NASDAQ:ACIU	AC Immune SA
12/11/2021	08:44	Dow Jones News	AC Immune Sees Positive Data in Trial for Alzheimer's Disease Treatment	NASDAQ:ACIU	AC Immune SA
31/08/2021	09:55	Dow Jones News	AC Immune Shares Rally on Renewed Hope for Semorinemab in Alzheimer's	NASDAQ:ACIU	AC Immune SA
31/08/2021	07:33	Dow Jones News	AC Immune: Semorinemab Meets Co-Primary Endpoint in Alzheimer's Disease	NASDAQ:ACIU	AC Immune SA
05/08/2021	16:16	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ACIU	AC Immune SA